Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI

PurposeThe aim of this study was to evaluate the diagnostic value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) derived kinetic parameters with high spatiotemporal resolution in discriminating malignant from normal prostate tissues.MethodsFifty patients with suspicious of maligna...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongjiang Zhang, Jing Yang, Kunhua Wu, Zujun Hou, Ji Du, Jianhua Yan, Ying Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1450388/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136504445173760
author Hongjiang Zhang
Jing Yang
Kunhua Wu
Zujun Hou
Ji Du
Jianhua Yan
Ying Zhao
author_facet Hongjiang Zhang
Jing Yang
Kunhua Wu
Zujun Hou
Ji Du
Jianhua Yan
Ying Zhao
author_sort Hongjiang Zhang
collection DOAJ
description PurposeThe aim of this study was to evaluate the diagnostic value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) derived kinetic parameters with high spatiotemporal resolution in discriminating malignant from normal prostate tissues.MethodsFifty patients with suspicious of malignant diseases in prostate were included in this study. Regions of interest (ROI) were manually delineated by experienced radiologists. Voxel-wise kinetic parameters were produced with the following tracer kinetic models (TKMs): Tofts model, extended Tofts model (ETM), Brix’s conventional two-compartment model (Brix), adiabatic tissue homogeneity model (ATH), and distributed parameter model (DP). The initial area under the signal-time curve (IAUC) with an uptake integral approach was also included. Mann–Whitney U test and receiver operating characteristic (ROC) curves were used to evaluate the capability of distinguishing tumor lesions from normal tissues. A p-value of 0.05 or less is considered statistically significant. ROI based parameters correlation analysis between DP and ETM were performed.Results624 lesions and 269 normal tissue ROIs were obtained. Thirty parameters were derived from the six kinetic models. Except for PS from Brix, statistically significant differences between lesions and normal tissues (P<0.05) were observed in other parameters.Ve from DP, ATH and Brix and PS from ATH have AUC values less than 0.6 in the ROC analysis. MTT, Vp and PS from DP, Ktrans from ETM and Tofts, E and PS from ATH, IAUC parameters and F from Brix have AUC values larger than 0.8. Ve and Vp from DP and ETM are correlated (r> 0.65). The correlation coefficient between Ktrans from ETM and PS from DP is 0.751.ConclusionMTT, Vp and PS from DP, Ktrans from ETM and Tofts, E and PS from ATH, F from Brix and IAUC parameters can be used to differentiate malignant lesions from normal tissues in the prostate.
format Article
id doaj-art-833fa2c2aeea4c068eac0ab6b69c5755
institution OA Journals
issn 2234-943X
language English
publishDate 2024-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-833fa2c2aeea4c068eac0ab6b69c57552025-08-20T02:31:08ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-12-011410.3389/fonc.2024.14503881450388Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRIHongjiang Zhang0Jing Yang1Kunhua Wu2Zujun Hou3Ji Du4Jianhua Yan5Ying Zhao6Department of Magnetic Resonance Imaging (MRI), The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Magnetic Resonance Imaging (MRI), The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Magnetic Resonance Imaging (MRI), The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Radiology, FISCA Laboratory for Advanced Imaging, Nanjing, ChinaDepartment of Magnetic Resonance Imaging (MRI), The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaDepartment of Nuclear Medicine, The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, ChinaDepartment of Magnetic Resonance Imaging (MRI), The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, ChinaPurposeThe aim of this study was to evaluate the diagnostic value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) derived kinetic parameters with high spatiotemporal resolution in discriminating malignant from normal prostate tissues.MethodsFifty patients with suspicious of malignant diseases in prostate were included in this study. Regions of interest (ROI) were manually delineated by experienced radiologists. Voxel-wise kinetic parameters were produced with the following tracer kinetic models (TKMs): Tofts model, extended Tofts model (ETM), Brix’s conventional two-compartment model (Brix), adiabatic tissue homogeneity model (ATH), and distributed parameter model (DP). The initial area under the signal-time curve (IAUC) with an uptake integral approach was also included. Mann–Whitney U test and receiver operating characteristic (ROC) curves were used to evaluate the capability of distinguishing tumor lesions from normal tissues. A p-value of 0.05 or less is considered statistically significant. ROI based parameters correlation analysis between DP and ETM were performed.Results624 lesions and 269 normal tissue ROIs were obtained. Thirty parameters were derived from the six kinetic models. Except for PS from Brix, statistically significant differences between lesions and normal tissues (P<0.05) were observed in other parameters.Ve from DP, ATH and Brix and PS from ATH have AUC values less than 0.6 in the ROC analysis. MTT, Vp and PS from DP, Ktrans from ETM and Tofts, E and PS from ATH, IAUC parameters and F from Brix have AUC values larger than 0.8. Ve and Vp from DP and ETM are correlated (r> 0.65). The correlation coefficient between Ktrans from ETM and PS from DP is 0.751.ConclusionMTT, Vp and PS from DP, Ktrans from ETM and Tofts, E and PS from ATH, F from Brix and IAUC parameters can be used to differentiate malignant lesions from normal tissues in the prostate.https://www.frontiersin.org/articles/10.3389/fonc.2024.1450388/fullDCE MRItracer kinetic modelingprostate cancerquantitativeGleason score
spellingShingle Hongjiang Zhang
Jing Yang
Kunhua Wu
Zujun Hou
Ji Du
Jianhua Yan
Ying Zhao
Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
Frontiers in Oncology
DCE MRI
tracer kinetic modeling
prostate cancer
quantitative
Gleason score
title Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
title_full Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
title_fullStr Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
title_full_unstemmed Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
title_short Comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast-enhanced MRI
title_sort comparison of tracer kinetic models in differentiating malignant from normal prostate tissue using dynamic contrast enhanced mri
topic DCE MRI
tracer kinetic modeling
prostate cancer
quantitative
Gleason score
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1450388/full
work_keys_str_mv AT hongjiangzhang comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT jingyang comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT kunhuawu comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT zujunhou comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT jidu comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT jianhuayan comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri
AT yingzhao comparisonoftracerkineticmodelsindifferentiatingmalignantfromnormalprostatetissueusingdynamiccontrastenhancedmri